Long-term use of 0.003% tacrolimus suspension for treatment of vernal keratoconjunctivitis

PURPOSE: To evaluate the safety and efficacy of 0.003% tacrolimus suspension for the treatment of refractory vernal keratoconjunctivitis (VKC). MATERIALS AND METHODS: This prospective study included 40 eyes of 20 patients with severe VKC. After discontinuing all other medications, patients were trea...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oman J Ophthalmol
Main Authors: Al-Amri, Abdulrahman Mohammed, Fiorentini, Sandra Flavia, Albarry, Maan A., Bamahfouz, Ashjan Yousef
Format: Artigo
Jezik:Inglês
Izdano: Medknow Publications & Media Pvt Ltd 2017
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5657154/
https://ncbi.nlm.nih.gov/pubmed/29118487
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ojo.OJO_232_2014
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki